arrow
O

Odirlei André Monticielo

Hospital de Clínicas de Porto Alegre
H指数:25
被引数:1,961

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Treatment patterns and outcomes of first lupus nephritis episode over 25 years in two Latin American cohorts

拉丁美洲两个队列中25年来首次狼疮肾炎发作的治疗模式与结局

Lupus
IF1.9
2026-07-010
PRE
Living with systemic lupus erythematosus in 2024: Latin American experience based on a patient survey

2024年系统性红斑狼疮患者的生活:基于拉丁美洲患者调查的经验

2025-12-050
PRE
International development and validation of a multilingual bank of items for the self-assessment of essential knowledge by lupus patients: the SLE Knowledge Assessment Score (SLAKE)

国际开发与验证一种多语言题库,用于狼疮患者的核心知识自我评估:系统性红斑狼疮知识评估量表(SLAKE)

2025-12-010
PRE
Comparison of the immunogenicity and safety among COVID-19 vaccines ChadOx-1, CoronaVac and BNT162b2 in systemic lupus erythematosus (SLE) patients: a prospective cohort

比较COVID-19疫苗ChadOx-1、CoronaVac和BNT162b2在系统性红斑狼疮(SLE)患者中的免疫原性和安全性:一项前瞻性队列研究

2025-11-220
PRE
Reply to the letter on Brazilian guidelines for the management of tuberculosis infection in immune-mediated inflammatory diseases: is retesting in latent tuberculosis screening appropriate and safe?

回复关于巴西免疫介导性炎症疾病中结核感染管理指南的信件:在潜伏性结核筛查中重新检测是否适当和安全?

2025-11-190
OA
Immunogenicity and safety to SARS-Cov-2 vaccination in patients with systemic vasculitis

系统性血管炎患者对SARS-Cov-2疫苗接种的免疫原性和安全性

2025-11-180
OAAI
Primary and Booster COVID-19 Vaccination in Patients with Sjögren’s Disease: Data from the Longitudinal SAFER Cohort Study

原发性及加强剂COVID-19疫苗接种在舍格伦综合征患者中的效果:纵向SAFER队列研究数据

2025-11-150
OAAI
Systematic Review and Network Meta-Analysis of Initial Treatments for Lupus Nephritis

系统性回顾和网络Meta分析:狼疮肾炎初始治疗方案

2025-07-030
OAAI
ERN ReCONNET–SLICC–SLEuro expert consensus on the therapeutic management of rare systemic lupus erythematosus manifestations

ERN ReCONNET–SLICC–SLEuro专家共识:罕见系统性红斑狼疮表现的药物治疗管理

2025-05-230
PRE
Prevalence of sarcopenia and its association with clinical features and health-related quality of life in Brazilian women with systemic lupus erythematosus

巴西系统性红斑狼疮女性中肌少症的患病率及其与临床特征和健康相关生活质量的关系

2025-04-280
OA
Immunogenicity of SARS-CoV-2 Vaccination Schedules Including a Booster Dose in Patients with Systemic Lupus Erythematosus: Data from a Prospective Multicenter Study

系统性红斑狼疮患者SARS-CoV-2疫苗接种计划包括加强剂量的免疫原性: 来自前瞻性多中心研究的数据

2025-01-270
OAAI
Immunogenicity and Safety According to Immunosuppressive Drugs and Different COVID-19 Vaccine Platforms in Immune-Mediated Disease: Data from SAFER Cohort
2024-12-030
OAAI
Predictors of Hospitalization in Breakthrough COVID-19 among Fully Vaccinated Individuals with Immune-Mediated Rheumatic Diseases: Data from SAFER-Study
2024-09-091
OAAI
IMMUNOGENICITY AND SAFETY OF COVID19 VACCINES IN PATIENTS WITH JUVENILE AUTOIMMUNE DISEASES: DATA FROM SAFER STUDY

COVID-19疫苗在青少年自身免疫性疾病患者中的免疫原性和安全性:SAFER研究数据

2024-06-010
PRE
BIVALENT MRNA COVID-19 VACCINE BOOSTER DOES NOT INCREASE THE RISK OF FLARE IN RHEUMATOID ARTHRITIS PATIENTS UNDER REAL LIFE SETTING - DATA FROM SAFER STUDY

双价mRNA COVID-19疫苗加强针在真实世界环境中不会增加类风湿关节炎患者的疾病复发风险——SAFER研究数据

2024-06-010
PRE
VITAMIN D SUPPLEMENTATION REDUCES IMMUNOGLOBULIN DEPOSITS IN THE BRAIN OF PRISTANE-INDUCED LUPUS MICE

维生素D补充剂可减少普里昂诱导的狼疮小鼠脑中的免疫球蛋白沉积

2024-06-010
PRE